Jones Soda (JSDA) 10-K 29 Mar 23 2022 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2022	Mar. 27, 2023	Jun. 30, 2022
Document Information [Line Items]
Entity Central Index Key	0001083522
Entity Registrant Name	JONES SODA CO
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2022
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Document Transition Report	false
Entity File Number	000-28820
Entity Incorporation, State or Country Code	WA
Entity Tax Identification Number	52-2336602
Entity Address, Address Line One	4786 1st Avenue South, Suite 103
Entity Address, City or Town	Seattle
Entity Address, State or Province	WA
Entity Address, Postal Zip Code	98134
City Area Code	206
Local Phone Number	624-3357
Title of 12(g) Security	Common Stock, no par value
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Public Float			$ 26,566,146
Entity Common Stock, Shares Outstanding		100,623,135
Auditor Firm ID	32
Auditor Name	ArmaninoLLP
Auditor Location	Bellevue, Washington

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 7,971	$ 4,667
Accounts receivable, net of allowance of $110 and $114, respectively	3,170	2,662
Inventory	2,621	1,923
Prefunded insurance premiums - Financing	612	903
Prepaid expenses and other current assets	601	358
Total current assets	14,975	10,513
Fixed assets, net of accumulated depreciation of $309 and $627, respectively	127	238
Right-of-use lease asset	0	365
Other assets	0	33
Total assets	15,102	11,149
Current liabilities:
Accounts payable	1,069	1,239
Accrued expenses	1,644	1,544
Insurance premium financing	612	903
Lease liability, current portion	0	109
Taxes payable	10	8
Current portion of accrued interest expense	0	55
Total current liabilities	3,335	4,488
Net convertible subordinated notes payable, net of current portion	0	1,778
Lease liability, net of current portion	0	266
Total liabilities	3,335	6,532
Shareholders’ equity:
Common stock, no par value: Authorized — 100,000,000; issued and outstanding shares — 64,977,677 shares and 61,975,748 shares, respectively	89,680	76,017
Accumulated other comprehensive income	287	396
Accumulated deficit	(78,200)	(71,796)
Total shareholders’ equity	11,767	4,617
Total liabilities and shareholders’ equity	15,102	11,149
Convertible Subordinated Notes Payable [Member]
Current liabilities:
Convertible notes payable	0	92
Contingent Convertible Debentures [Member]
Current liabilities:
Convertible notes payable	$ 0	$ 538

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($)	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Accounts receivable, allowance	$ 110,000	$ 119,000	$ 111,000	$ 114,000
Fixed assets, accumulated depreciation	$ 309,000			$ 627,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenue	$ 19,085	$ 14,792
Cost of goods sold	13,942	10,394
Gross profit	5,143	4,398
Operating expenses:
Selling and marketing	4,965	3,003
General and administrative	6,271	3,302
Total operating expenses	11,236	6,305
Loss from operations	(6,093)	(1,907)
Interest income	6	4
Interest expense	(377)	(225)
Other income, net	88	344
Loss before income taxes	6,376	1,784
Income tax expense	(28)	(27)
Net loss	$ (6,404)	$ (1,811)
Net income (loss) per share - basic and diluted (in dollars per share)	$ (0.07)	$ (0.03)
Weighted average common shares outstanding - basic and diluted (in shares)	94,177,863	65,542,609

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Net loss	$ (6,404)	$ (1,811)
Other comprehensive loss:
Foreign currency translation adjustment	(109)	(15)
Total comprehensive loss	$ (6,513)	$ (1,826)

Consolidated Statements of Shar

Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Common Stock Including Additional Paid in Capital [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2020	61,975,748
Balance at Dec. 31, 2020	$ 73,953	$ 411	$ (69,985)	$ 4,379
Stock-based compensation expense (in shares)	0
Stock-based compensation expense	$ 147	0	0	147
Common stock issued upon conversion of notes payable (in shares)	5,064,137
Common stock issued upon conversion of notes payable	$ 1,621	0	0	$ 1,621
Issuance of common stock upon exercise of stock options (in shares)	801,056			797,306
Issuance of common stock upon exercise of stock options	$ 296	0	0	$ 296
Net Income (Loss) Attributable to Parent, Total	0	0	(1,811)	(1,811)
Other comprehensive income (loss)	$ 0	(15)	0	(15)
Balance (in shares) at Dec. 31, 2021	67,840,941
Balance at Dec. 31, 2021	$ 76,017	396	(71,796)	4,617
Stock-based compensation expense (in shares)	1,950,000
Stock-based compensation expense	$ 1,364	0	0	1,364
Common stock issued upon conversion of notes payable (in shares)	10,472,146
Common stock issued upon conversion of notes payable	$ 5,147	0	0	$ 5,147
Issuance of common stock upon exercise of stock options (in shares)				0
Net Income (Loss) Attributable to Parent, Total	0	0	(6,404)	$ (6,404)
Other comprehensive income (loss)	$ 0	(109)	0	(109)
Common stock and warrants issued, net of closing costs of $848 (in shares)	20,000,048
Common stock and warrants issued, net of closing costs of $848	$ 7,152	0	0	7,152
Balance (in shares) at Dec. 31, 2022	100,263,135
Balance at Dec. 31, 2022	$ 89,680	$ 287	$ (78,200)	$ 11,767

Consolidated Statements of Sh_2

Consolidated Statements of Shareholders' Equity (Parentheticals) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Net of closing costs	$ 848

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	3 Months Ended	6 Months Ended	12 Months Ended
	Mar. 31, 2022	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
OPERATING ACTIVITIES:
Net loss	$ (1,664,000)	$ (3,099,000)	$ (6,404,000)	$ (1,811,000)
Adjustments to reconcile net loss to net cash flows from operating activities:
Depreciation and amortization	247,000	382,000	414,000	166,000
Stock-based compensation	268,000	386,000	1,364,000	144,000
Change in allowance for doubtful accounts	(3,000)	5,000	(4,000)	21,000
Forgiveness of PPP SBA loan			0	(335,000)
Loss (gain) on sale of fixed asset			(31,000)	5,000
Gain on insurance claim			(23,000)	0
Changes in operating assets and liabilities:
Accounts receivable	(545,000)	(1,428,000)	(542,000)	(1,129,000)
Inventory	(982,000)	(916,000)	(714,000)	(66,000)
Prefunded insurance premiums from financing	306,000	614,000	292,000	(903,000)
Prepaid expenses and other current assets	(119,000)	(585,000)	(243,000)	(164,000)
Other assets	(25,000)	(25,000)	35,000	0
Accounts payable	496,000	383,000	(167,000)	(147,000)
Accrued expenses	(66,000)	(43,000)	73,000	783,000
Taxes payable	1,000	6,000	3,000	1,000
Other liabilities	1,000	1,000	(10,000)	4,000
Net cash used in operating activities	(2,035,000)	(4,269,000)	(5,957,000)	(3,431,000)
INVESTING ACTIVITIES:
Proceeds from insurance claim on property damage			31,000	0
Proceeds from sale of fixed assets			98,000	4,000
Purchase of fixed assets			(29,000)	(35,000)
Net cash from investing activities			100,000	(31,000)
FINANCING ACTIVITIES:
Proceeds from exercise of stock options			0	296,000
Proceeds from issuance of convertible notes	2,354,000	2,354,000
Proceeds from issuance of convertible notes	(2,354,000)	(2,354,000)
Repayments on Insurance financing, net of additional financing	(306,000)	(614,000)	(292,000)	0
Additional financing for insurance premiums, net of repayments			0	903,000
Proceeds from issuance of common stock and warrants, net	7,152,000	7,152,000	7,152,000	0
Net cash provided by financing activities	9,200,000	8,892,000	9,214,000	3,515,000
Net change in cash and cash equivalents			3,357,000	53,000
Effect of exchange rate changes on cash			(53,000)	0
Cash and cash equivalents, beginning of period	4,667,000	$ 4,667,000	4,667,000	4,614,000
Cash and cash equivalents, end of period			7,971,000	4,667,000
Supplemental disclosure:
Interest			47,000	0
Income taxes			23,000	24,000
Supplemental disclosure of non-cash transactions:
Conversion of notes payable			5,147,000	1,621,000
Beneficial conversion feature on convertible notes and accrued interest			0	4,000
Convertible Subordinated Notes Payable [Member]
FINANCING ACTIVITIES:
Proceeds from issuance of convertible notes			2,354,000	1,778,000
Proceeds from issuance of convertible notes			(2,354,000)	(1,778,000)
Contingent Convertible Debentures [Member]
FINANCING ACTIVITIES:
Proceeds from issuance of convertible notes	3,000,000		0	538,000
Proceeds from issuance of convertible notes	$ (3,000,000)		$ 0	$ (538,000)

Note 1 - Nature of Operations a

Note 1 - Nature of Operations and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Significant Accounting Policies [Text Block]	1. Nature of Operations and Summary of Significant Accounting Policies Jones Soda Co. develops, produces, markets and distributes premium beverages which it sells and distributes primarily in the United States and Canada through its network of independent distributors and directly to its national and regional retail accounts. In addition, following the closing of the Plan of Arrangement (See note 7 We are a Washington corporation and have five Basis of presentation and consolidation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and the Securities and Exchange Commission (SEC) rules and regulations applicable to financial reporting. The consolidated financial statements include our accounts and accounts of our wholly owned subsidiaries. All intercompany transactions between us and our subsidiaries have been eliminated in consolidation. Liquidity As of December 31, 2022 2021, 2022 2021 2022. For the year ended December 31, 2022, 5 May 16, 2022.Additionally, one one We incurred a net loss of approximately $6.4 million for the year ended December 31, 2022 December 31, 2021. December 31, 2022 December 31, 2021. During 2022 2021, may may We may may may may may may not may may not may may may not As of the date of this Report, as a result of our cash on hand from the beforementioned financings, we believe that our current cash and cash equivalents will be sufficient to meet the Company’s funding requirements for one Restatement of Previously Issued Consolidated Financial Statements for Errors surrounding short-term financing As part of preparing our consolidated financial statements as at and for the year ended December 31, 2022, December 31, 2021, November 15, 2021, one January 15, 2022, April 15, 2022, July 15, 2022 July 15, 2022. December 31, 2021, not December 31, 2021, As a result of the identification of this error, we concluded that the previously issued consolidated financial statements as at and for the year ended December 31, 2021, December 31, 2021, This error did not The impacts of this correction to fiscal year 2021 As of December 31, 2021 (In thousands) Consolidated Balance Sheet: As Reported Restatement As Restated Current assets: Cash and cash equivalents $ 4,667 $ - $ 4,667 Accounts receivable, net of allowance of $ 114 2,662 - 2,662 Inventory 1,923 - 1,923 Prefunded insurance premiums from financing - 903 903 Prepaid expenses and other current assets 358 - 358 Total current assets $ 9,610 $ 903 $ 10,513 Current liabilities: Accounts payable 1,239 - 1,239 Accrued expenses 1,544 - 1,544 Insurance Premium Financing - 903 903 Lease liability, current portion 109 - 109 Taxes payable 8 - 8 Current portion of convertible subordinated notes payable, net 92 - 92 Current portion of accrued interest expense 55 - 55 2022 Financing Proceeds Received, Net of Closing Costs 538 - 538 Total current liabilities $ 3,585 $ 903 $ 4,488 Year Ended December 31, 2021 (In thousands) Consolidated Statement of Cash flows: As Reported Restatement As Restated OPERATING ACTIVITIES: Net loss $ (1,811) $ - $ (1,811) Adjustments to reconcile net loss to net cash flows from operating activities: Depreciation and amortization 166 - 166 Stock-based compensation 144 - 144 Change in allowance for doubtful accounts 21 - 21 Forgiveness of PPP SBA loan (335) - (335) Loss (gain) on sale of fixed asset 5 - 5 Changes in operating assets and liabilities: Accounts receivable (1,129) - (1,129) Inventory (66) - (66) Prefunded insurance premiums from financing - (903) (903) Prepaid expenses and other current assets (164) - (164) Accounts payable (147) - (147) Accrued expenses 783 - 783 Taxes payable 1 - 1 Other liabilities 4 - 4 Net cash used in operating activities (2,528) (903) (3,431) FINANCING ACTIVITIES: Proceeds from exercise of stock options $ 296 $ - $ 296 Proceeds from issuance of convertible notes, net 1,778 - 1,778 Proceeds from 2022 convertible notes prior to close, net 538 - 538 Additional financing for insurance premiums, net of repayments - 903 903 Net cash provided by financing activities $ 2,612 $ 903 $ 3,515 The impacts of this correction for the quarter-ending March 31, 2022 As of March 31, 2022 (In thousands) Consolidated Balance Sheet: As Reported Restatement As Restated Current assets: Cash and cash equivalents $ 11,856 $ - $ 11,856 Accounts receivable, net of allowance of $ 111 3,216 - 3,216 Inventory 2,907 - 2,907 Prefunded insurance premiums from financing - 597 597 Prepaid expenses and other current assets 477 - 477 Total current assets $ 18,456 $ 597 $ 19,053 Current liabilities: Accounts payable 1,735 - 1,735 Accrued expenses 1,526 - 1,526 Insurance Premium Financing - 597 597 Lease liability, current portion 111 - 111 Taxes payable 9 - 9 Current portion of convertible subordinated notes payable, net 2,893 - 2,893 Total current liabilities $ 6,274 $ 597 $ 6,871 Quarter Ended March 31, 2022 (In thousands) Consolidated Statement of Cash flows: As Reported Restatement As Restated OPERATING ACTIVITIES: Net loss $ (1,664) $ - $ (1,664) Adjustments to reconcile net loss to net cash flows from operating activities: Depreciation and amortization 247 - 247 Stock-based compensation 268 - 268 Change in allowance for doubtful accounts (3) - (3) Changes in operating assets and liabilities: Accounts receivable (545) - (545) Inventory (982) - (982) Prefunded insurance premiums from financing - 306 306 Prepaid expenses and other current assets (119) - (119) Other assets 25 - 25 Accounts payable 496 - 496 Accrued expenses (66) - (66) Taxes payable 1 - 1 Other liabilities 1 - 1 Net cash used in operating activities $ (2,341) $ 306 $ (2,035) FINANCING ACTIVITIES: Proceeds from issuance of convertible notes, net $ 2,354 $ - $ 2,354 Repayments on Insurance financing, net of additional financing - (306) (306) Proceeds from issuance of common stock and warrants, net 7,152 - 7,152 Net cash provided by financing activities $ 9,506 $ (306) $ 9,200 The impacts of this correction for the six June 30, 2022 As of June 30, 2022 (In thousands) Consolidated Balance Sheet: As Reported Restatement As Restated Current assets: Cash and cash equivalents $ 9,285 $ - $ 9,285 Accounts receivable, net of allowance of $ 119 4,071 - 4,071 Inventory 2,833 - 2,833 Prefunded insurance premiums from financing - 289 289 Prepaid expenses and other current assets 944 - 944 Total current assets $ 17,133 $ 289 $ 17,422 Current liabilities: Accounts payable 1,619 - 1,619 Accrued expenses 1,529 - 1,529 Insurance Premium Financing - 289 289 Lease liability, current portion 114 - 114 Taxes payable 14 - 14 Total current liabilities $ 3,276 $ 289 $ 3,565 Six months Ended June 30, 2022 (In thousands) Consolidated Statement of Cash flows: As Reported Restatement As Restated OPERATING ACTIVITIES: Net loss $ (3,099) $ - $ (3,099) Adjustments to reconcile net loss to net cash flows from operating activities: Depreciation and amortization 382 - 382 Stock-based compensation 386 - 386 Change in allowance for doubtful accounts 5 - 5 Changes in operating assets and liabilities: Accounts receivable (1,428) - (1,428) Inventory (916) - (916) Prefunded insurance premiums from financing - 614 614 Prepaid expenses and other current assets (585) - (585) Other assets 25 - 25 Accounts payable 383 - 383 Accrued expenses (43) - (43) Taxes payable 6 - 6 Other liabilities 1 - 1 Net cash used in operating activities $ (4,883) $ 614 $ (4,269) FINANCING ACTIVITIES: Proceeds from issuance of convertible notes, net $ 2,354 $ - $ 2,354 Repayments on Insurance financing, net of additional financing - (614) (614) Proceeds from issuance of common stock and warrants, net 7,152 - 7,152 Net cash provided by financing activities $ 9,506 $ (614) $ 8,892 The impacts of the restatement have been reflected throughout the financial statements, including the applicable footnotes, as appropriate. Use of estimates The preparation of the consolidated financial statements requires management to make a number of estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not Cash and cash equivalents We consider all highly liquid short-term investments with an original or remaining maturity of three Fair value of financial instruments Applicable accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). We measure our assets and liabilities using inputs from the following three 1 2 not 3 The carrying amounts for cash and cash equivalents, receivables, and payables approximate fair value due to the short-term maturity of these instruments. Accounts receivable Our accounts receivable balance primarily includes balances from trade sales to distributors and retail customers. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance for doubtful accounts based primarily on historical write-off experience. Account balances that are deemed uncollectible, are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Allowances for doubtful accounts of approximately $110,000 and $114,000 as of December 31, 2022 2021, Activity in the allowance for doubtful accounts consists of the following for the years ended December 31 ( 2022 2021 Balance, beginning of year $ 114 $ 93 Net charges to bad debt expense (5 ) 42 Recoveries (write-offs) 1 (21 ) Balance, end of year $ 110 $ 114 As of December 31, 2022, two December 31, 2021, one Inventories Inventories consist of raw materials and finished goods and are stated at the lower of cost or net realizable value and include adjustments for estimated obsolete or excess inventory. Cost is based on actual cost on a first first twelve may December 31, 2022 2021, Fixed assets Fixed assets are recorded at cost less accumulated depreciation and are depreciated on the declining balance basis over the estimated useful lives of the assets as follows: Asset Rate Equipment 20% to 30% Vehicles and office and computer equipment 30% Impairment of long-lived assets Long-lived assets, which include fixed assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not Foreign currency translation The functional currency of our Canadian subsidiary is the Canadian dollar. We translate assets and liabilities related to these operations to U.S. dollars at the exchange rate in effect at the date of the consolidated balance sheet; we convert revenues and expenses into U.S. dollars using the average monthly exchange rates. Translation gains and losses are reported as a separate component of accumulated other comprehensive income. Transaction gains and losses arising from the transactions denominated in a currency other than the functional currency are included in other expense, net in the accompanying consolidated statement of operations. Net transaction loss was $7,000 for 2022 2021. Revenue recognition The Company recognizes revenue under Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers 606” five five Step 1: Step 2: Step 3: Step 4: Step 5: See Note 11, Because the Company’s agreements have an expected duration of one 606 10 50 14 not Our contracts have a single performance obligation which is satisfied at the point in time when the customer has title and the significant risks and rewards of ownership of the product. Title and the significant risk and rewards of ownership are deemed to transfer when products are loaded onto a truck for shipment or Free on Board (“FOB”) shipping point. The Company primarily receives fixed consideration for sales of product, subject to adjustment as described below. Shipping and handling amounts paid by customers are primarily for online orders, and are included in revenue, and totaled $163,000 and $120,000 for the years ended December 31, 2022 2021, Revenue is recorded net of provisions for discounts, slotting fees payable by us to retailers to stock our products and promotion allowances. Discounts, slotting fees and promotional allowances vary the consideration the Company is entitled to in exchange for the sale of products to distributors. The Company estimates these discounts, slotting fees and promotional allowances in the same period that the revenue is recognized for product sales to customers. These estimates are based on contract terms and our historical experience with similar programs and require management judgement with respect to estimating customer participation and performance levels. Differences between estimated expense and actual costs are normally insignificant and are recognized in earnings in the period such differences are determined. The amount of revenue recognized represents the amount that will not December 31, 2022 2021, All sales to distributors and customers are generally final. In limited instances we may not 30 15 Advertising costs Advertising costs, which also include promotions and sponsorships, are expensed as incurred. During the years ended December 31, 2022 2021, Income taxes We account for income taxes by recognizing the amount of taxes payable for the current year and deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in our financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. We perform periodic evaluations of recorded tax assets and liabilities and maintain a valuation allowance, if considered necessary based on whether they are more likely than not December 31, 2022 2021. Net loss per share Basic net loss per share is computed using the weighted average number of common shares outstanding during the periods. Diluted earnings per share is computed by adjusting the weighted average number of common shares by the effective net exercise or conversion of all dilutive securities. Due to the net loss in 2022 2021, 2018 Comprehensive loss Comprehensive loss is comprised of net loss and translation adjustments. We do not Seasonality Our sales are seasonal and we experience fluctuations in quarterly results as a result of many factors. We historically have generated a greater percentage of our revenues during the warm weather months of April September. may may not not Deferred financing costs We defer costs related to the issuance of debt which are included on the accompanying balance sheets as a deduction from the debt liability. Deferred financing costs are amortized over the term of the related loan and are included as a component of interest expense on the accompanying consolidated statements of operations. Recent accounting guidance No 2022

Note 2 - Inventory

Note 2 - Inventory	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Inventory Disclosure [Text Block]	2. Inventory Inventory consisted of the following as of December 31 ( December 31, 2022 December 31, 2021 Finished goods $ 1,234 $ 1,361 Raw materials 1,387 562 $ 2,621 $ 1,923 Finished goods primarily include product ready for shipment, as well as promotional merchandise held for sale. Raw materials primarily include ingredients, concentrate and packaging.

Note 3 - Fixed Assets

Note 3 - Fixed Assets	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	3. Fixed Assets, net Fixed assets, net consisted of the following as of December 31 ( 2022 2021 Vehicles $ 37 $ 496 Equipment 210 210 Office and computer equipment 189 159 436 865 Accumulated depreciation (309 ) (627 ) $ 127 $ 238 Depreciation expense was $66,000 and $93,000, for the years ended December 31, 2022 2021, December 31, 2022. December 31, 2022.

Note 4 - Accrued Expenses

Note 4 - Accrued Expenses	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	4. Accrued Expenses Accrued expenses consisted of the following as of December 31 ( 2022 2021 Employee benefits $ 604 $ 405 Selling and marketing 465 354 Other accruals 575 785 $ 1,644 $ 1,544

Note 5 - Convertible Debentures

Note 5 - Convertible Debentures	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Convertible Subordinated Notes Payable [Text Block]	5. Convertible Debentures 2018 Convertible Subordinated Note Payable On March 23, 2018, April 18, 2018, “2018 The 2018 four March 23, 2022 , April 18, 2022. 2018 2018 $0.32 No The 2018 The fair value of our common stock on the March 23, 2018, 2018 2018 April 18, 2018, 2018 not 2018 March 23, 2018 2018 2018 April 18, 2022 2018 September 30, 2022 2021 Unsecured Convertible Debenture On July 14, 2021, July 14, 2023 ( “2021 1 one one one 2021 1 December 31, 2021. The closing of the Plan of Arrangement resulted in the automatic conversion of the 2021 2021 2022 Unsecured Convertible Debenture On February 9, 2022 , February 9, 2023 ( May 16, 2022 . February 9, 2023 ( April 1, 2022 . December 31, 2021 March 31, 2022 . May 16, 2022 September 30, 2022

Note 6 - Lease Obligations

Note 6 - Lease Obligations	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Lessee, Operating Leases [Text Block]	6. Lease Obligations During the year ended December 31, 2022 five February 2020, February 28, 2025. On September 1, 2022 not not not 12 During the year ended December 31, 2022 2021, December 31, 2022,

Note 7 - Shareholders' Equity

Note 7 - Shareholders' Equity	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	7. Shareholders Equity On May 16, 2022, 2022 " 2022 2011 2022 2022 2011 2011 2022 1,936,074 shares of common stock reserved under the terms of our 2011 “2011 2022 Under the terms of the 2022 may ten December 31, 2022, (a) Stock options: A summary of our stock option activity is as follows: Outstanding Options Number of Shares Weighted Average Exercise Price (Per Share) Balance at January 1, 2022 3,405,511 $ 0.38 Options granted 828,148 0.51 Options forfeited/expired (864,327 ) 0.41 Balance at December 31, 2022 3,369,332 $ 0.41 Exercisable, December 31, 2022 2,460,674 $ 0.34 Vested and expected to vest 3,116,129 $ 0.40 Outstanding Options Number of Shares Weighted Average Exercise Price (Per Share) Balance at January 1, 2021 3,589,783 $ 0.36 Options granted 1,423,450 0.49 Options exercised (797,306 ) 0.37 Options forfeited/expired (810,416 ) 0.48 Balance at December 31, 2021 3,405,511 $ 0.38 Exercisable, December 31, 2021 1,616,439 $ 0.34 Vested and expected to vest 2,808,039 $ 0.37 The following table summarizes information about stock options outstanding and exercisable under our stock incentive plans at December 31, 2022: Number Outstanding Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price Per Share Number Exercisable Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price Per Share $0.15 to $0.50 2,835,258 7.13 $ 0.34 2,240,258 6.55 $ 0.31 $0.51 to $1.09 529,074 8.65 0.78 215,416 8.26 0.73 $1.10 to $2.99 5,000 8.59 1.33 5,000 8.59 1.33 3,369,332 7.37 0.41 2,460,674 6.70 0.34 (b) Restricted stock awards: Beginning on May 13, 2022 2022 January 1, 2020 February 15, 2022, first first January February 15, 2022, first $25,000 first first 2022 2011 2022 On December 30, 2022, 2022 2022 no 2022 August 2022. There was no 2021. 2022 Restricted Shares Weighted-Average Grant Date Fair Value per share Weighted-Average Contractual Life (years) Non-vested restricted stock at January 1, 2022 - $ - - Granted 4,920,000 0.20 - Vested (70,000 ) 0.22 Cancelled/expired/rescinded (4,850,000 ) 0.20 Non-vested restricted stock at December 31, 2022 - $ - - (c) Stock-based compensation expense: Stock-based compensation expense is recognized using the straight-line attribution method over the employees’ requisite service period. We recognize compensation expense for only the portion of stock options or restricted stock expected to vest. Therefore, we apply estimated forfeiture rates that are derived from historical employee termination behavior. If the actual number of forfeitures differs from those estimated by management, additional adjustments to stock-based compensation expense may At December 31, 2022, The following table summarizes the stock-based compensation expense (in thousands): Year Ended December 31, 2022 2021 Stock options $ 353 $ 162 Pinestar warrants (defined below) 76 - Restricted stock 935 12 $ 1,364 $ 174 Income statement account: Selling and marketing $ 843 $ 65 General and administrative 521 109 $ 1,364 $ 174 We employ the following key weighted-average assumptions in determining the fair value of stock options, using the Black-Scholes option pricing model and the simplified method to estimate the expected term of “plain vanilla” options: Year Ended December 31, 2022 2021 Expected dividend yield — — Expected stock price volatility 79.3 % 74.7 % Risk-free interest rate 2.2 % 0.9 % Expected term (in years) 6.0 5.8 Weighted-average grant date fair-value $ 0.35 $ 0.32 During the year ended December 31, 2022, The aggregate intrinsic value of stock options outstanding at December 31, 2022 2021 December 31, 2022 2021 zero December 31, 2022 2021, zero (d) Closing of the Pinestar Gold Inc. - Plan of Arrangement: On February 15, 2022, one one In connection with the Plan of Arrangement, Pinestar completed the Pinestar Subscription Receipt Offering for aggregate net proceeds of $7,152,000, at a price per subscription receipt equal to $0.50. As part of the closing of the Plan of Arrangement, each such subscription receipt automatically converted into one one 1:1 The issuance of Jones Shares to the holders of Pinestar Shares (including Pinestar Shares received upon the conversion of the subscription receipts issued in the Pinestar Subscription Receipt Offering) in the Plan of Arrangement was exempt from the registration requirements under the United States Securities Act of 1933, 3 10 one The following table summarizes the Company's outstanding warrants as of December 31, 2022: Number Outstanding Remaining Contractual Life (Years) Exercise Price Per Share Number Exercisable Jones Special Warrants (1) 26,047,137 1.20 $ 0.63 USD 26,047,137 Pinestar Warrants (2) 1,674,808 1.25 0.06 CAD 1,674,808 Outstanding Warrants as of December 31, 2022 27,721,945 27,721,945 ( 1 2021 2022 ( 2 one two 2022 December 31, 2022.

Note 8 - Employee 401(k) Plan

Note 8 - Employee 401(k) Plan	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Compensation and Employee Benefit Plans [Text Block]	8. Employee 401 We have a 401 one three may 401 not not 401 December 31, 2022 2021. 401 2023 2022

Note 9 - Commitments and Contin

Note 9 - Commitments and Contingencies	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	9. Commitments and Contingencies Commitments As of December 31, 2022, 2023. Legal proceedings We are or may not

Note 10 - Income Taxes

Note 10 - Income Taxes	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Income Tax Disclosure [Text Block]	10. Income Taxes The provision for income taxes consisted of the following for the years ended December 31 ( 2022 2021 Current State $ 7 $ 4 Foreign 21 23 Provision for income taxes $ 28 $ 27 Loss before provision for income taxes was as follows for the years ended December 31 ( 2022 2021 United States $ (6,469 ) $ (1,881 ) Foreign 93 97 Total $ (6,376 ) $ (1,784 ) The items accounting for the difference between income taxes computed at the federal statutory rate and the provision for income taxes are as follows: 2022 2021 Federal statutory rate 21.00 % 21.00 % Effect of: Permanent differences (1.17 ) 3.84 Stock Compensation (0.85 ) 0.11 State income taxes, net of federal benefit 0.77 3.10 Change in valuation allowance (16.20 ) (10.27 ) Other, net (3.99 ) (19.30 ) Provision for income taxes (0.44 )% (1.51 )% Deferred income taxes reflect the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred income taxes were as follows (in thousands): 2022 2021 Federal and state net operating loss carryforwards $ 15,765 $ 14,896 Stock-based compensation 212 125 Other, net 205 157 Total deferred tax asset 16,182 15,178 Valuation allowance (16,182 ) (15,178 Net deferred tax asset $ — $ — We continue to experience significant losses in our U.S. operations that are material to our decision to maintain a full valuation allowance against our net U.S. deferred tax assets. This is due to the fact that the relevant accounting guidance puts more weight on the negative objective evidence of cumulative losses in recent years than the positive subjective evidence of future projections of pretax income. For the years ended December 31, 2022 December 31, 2021, We continually analyze the realizability of our deferred tax assets, but we reasonably expect to continue to record a full valuation allowance on future U.S tax benefits until we sustain an appropriate level of taxable income through improved U.S. operations and tax planning strategies. At December 31, 2022, 2023. may may 382 There are no uncertain tax positions to recognize as of December 31, 2022 2021. The tax years that remain open to examination by the taxing authorities are 2017 2021, On March 27, 2020 no December 31, 2022 2021.

Note 11 - Segment Information

Note 11 - Segment Information	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	11. Segment Information We have one December 31 Year Ended December 31, 2022 2021 Revenue: United States $ 15,313 $ 11,385 Canada 3,609 3,240 Other countries 163 167 Total revenue $ 19,085 $ 14,792 During the year ended December 31, 2022, one December 31, 2021 one

Note 12 - Insurance Premium Fin

Note 12 - Insurance Premium Financing	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Insurance Disclosure [Text Block]	12. Insurance Premium Financing Restatement of Previously Issued Consolidated Financial Statements for Errors surrounding short-term financing Prior year amounts have been restated to reflect the correction of the error discussed in Note 1, Effective November 15, 2021, one January 15, 2022, April 15, 2022, July 15, 2022, no Effective November 15, 2022, one January 15, 2023, April 15, 2023, July 15, 2023, no

Note 13 - Related Party Transac

Note 13 - Related Party Transaction	12 Months Ended
	Dec. 31, 2022
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	13. Related party Transactions On January 6, 2022 2022 December 31, 2022. December 31, 2021, not On February 9, 2022, 24 May 2022. Jamie Colbourne, a director and the former Chairman of our Board of Directors and former Interim Chief Financial Officer, Mark Murray, our President and Chief Executive Officer and a member our Board of Directors, former director Jeffrey Anderson, current director Clive Sirkin and current Chairman of the Board Paul Norman, each acquired $200,000 in subscription receipts in Pinestar Gold Inc., and consequently each of these related persons acquired 400,000 shares of our common stock and 400,000 Jones Special Warrants (exercisable into shares of our common stock at an exercise price of $0.625 per share) in connection with the closing of the plan of arrangement under the Business Corporations Act (British Columbia) on February 15, 2022. Additionally, during the year ended December 31, 2022, 7

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2022
Accounting Policies [Abstract]
Basis of Accounting, Policy [Policy Text Block]	Basis of presentation and consolidation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) and the Securities and Exchange Commission (SEC) rules and regulations applicable to financial reporting. The consolidated financial statements include our accounts and accounts of our wholly owned subsidiaries. All intercompany transactions between us and our subsidiaries have been eliminated in consolidation.
Going Concern [Policy Text Block]	Liquidity As of December 31, 2022 2021, 2022 2021 2022. For the year ended December 31, 2022, 5 May 16, 2022.Additionally, one one We incurred a net loss of approximately $6.4 million for the year ended December 31, 2022 December 31, 2021. December 31, 2022 December 31, 2021. During 2022 2021, may may We may may may may may may not may may not may may may not As of the date of this Report, as a result of our cash on hand from the beforementioned financings, we believe that our current cash and cash equivalents will be sufficient to meet the Company’s funding requirements for one
Reclassification, Comparability Adjustment [Policy Text Block]	Restatement of Previously Issued Consolidated Financial Statements for Errors surrounding short-term financing As part of preparing our consolidated financial statements as at and for the year ended December 31, 2022, December 31, 2021, November 15, 2021, one January 15, 2022, April 15, 2022, July 15, 2022 July 15, 2022. December 31, 2021, not December 31, 2021, As a result of the identification of this error, we concluded that the previously issued consolidated financial statements as at and for the year ended December 31, 2021, December 31, 2021, This error did not The impacts of this correction to fiscal year 2021 As of December 31, 2021 (In thousands) Consolidated Balance Sheet: As Reported Restatement As Restated Current assets: Cash and cash equivalents $ 4,667 $ - $ 4,667 Accounts receivable, net of allowance of $ 114 2,662 - 2,662 Inventory 1,923 - 1,923 Prefunded insurance premiums from financing - 903 903 Prepaid expenses and other current assets 358 - 358 Total current assets $ 9,610 $ 903 $ 10,513 Current liabilities: Accounts payable 1,239 - 1,239 Accrued expenses 1,544 - 1,544 Insurance Premium Financing - 903 903 Lease liability, current portion 109 - 109 Taxes payable 8 - 8 Current portion of convertible subordinated notes payable, net 92 - 92 Current portion of accrued interest expense 55 - 55 2022 Financing Proceeds Received, Net of Closing Costs 538 - 538 Total current liabilities $ 3,585 $ 903 $ 4,488 Year Ended December 31, 2021 (In thousands) Consolidated Statement of Cash flows: As Reported Restatement As Restated OPERATING ACTIVITIES: Net loss $ (1,811) $ - $ (1,811) Adjustments to reconcile net loss to net cash flows from operating activities: Depreciation and amortization 166 - 166 Stock-based compensation 144 - 144 Change in allowance for doubtful accounts 21 - 21 Forgiveness of PPP SBA loan (335) - (335) Loss (gain) on sale of fixed asset 5 - 5 Changes in operating assets and liabilities: Accounts receivable (1,129) - (1,129) Inventory (66) - (66) Prefunded insurance premiums from financing - (903) (903) Prepaid expenses and other current assets (164) - (164) Accounts payable (147) - (147) Accrued expenses 783 - 783 Taxes payable 1 - 1 Other liabilities 4 - 4 Net cash used in operating activities (2,528) (903) (3,431) FINANCING ACTIVITIES: Proceeds from exercise of stock options $ 296 $ - $ 296 Proceeds from issuance of convertible notes, net 1,778 - 1,778 Proceeds from 2022 convertible notes prior to close, net 538 - 538 Additional financing for insurance premiums, net of repayments - 903 903 Net cash provided by financing activities $ 2,612 $ 903 $ 3,515 The impacts of this correction for the quarter-ending March 31, 2022 As of March 31, 2022 (In thousands) Consolidated Balance Sheet: As Reported Restatement As Restated Current assets: Cash and cash equivalents $ 11,856 $ - $ 11,856 Accounts receivable, net of allowance of $ 111 3,216 - 3,216 Inventory 2,907 - 2,907 Prefunded insurance premiums from financing - 597 597 Prepaid expenses and other current assets 477 - 477 Total current assets $ 18,456 $ 597 $ 19,053 Current liabilities: Accounts payable 1,735 - 1,735 Accrued expenses 1,526 - 1,526 Insurance Premium Financing - 597 597 Lease liability, current portion 111 - 111 Taxes payable 9 - 9 Current portion of convertible subordinated notes payable, net 2,893 - 2,893 Total current liabilities $ 6,274 $ 597 $ 6,871 Quarter Ended March 31, 2022 (In thousands) Consolidated Statement of Cash flows: As Reported Restatement As Restated OPERATING ACTIVITIES: Net loss $ (1,664) $ - $ (1,664) Adjustments to reconcile net loss to net cash flows from operating activities: Depreciation and amortization 247 - 247 Stock-based compensation 268 - 268 Change in allowance for doubtful accounts (3) - (3) Changes in operating assets and liabilities: Accounts receivable (545) - (545) Inventory (982) - (982) Prefunded insurance premiums from financing - 306 306 Prepaid expenses and other current assets (119) - (119) Other assets 25 - 25 Accounts payable 496 - 496 Accrued expenses (66) - (66) Taxes payable 1 - 1 Other liabilities 1 - 1 Net cash used in operating activities $ (2,341) $ 306 $ (2,035) FINANCING ACTIVITIES: Proceeds from issuance of convertible notes, net $ 2,354 $ - $ 2,354 Repayments on Insurance financing, net of additional financing - (306) (306) Proceeds from issuance of common stock and warrants, net 7,152 - 7,152 Net cash provided by financing activities $ 9,506 $ (306) $ 9,200 The impacts of this correction for the six June 30, 2022 As of June 30, 2022 (In thousands) Consolidated Balance Sheet: As Reported Restatement As Restated Current assets: Cash and cash equivalents $ 9,285 $ - $ 9,285 Accounts receivable, net of allowance of $ 119 4,071 - 4,071 Inventory 2,833 - 2,833 Prefunded insurance premiums from financing - 289 289 Prepaid expenses and other current assets 944 - 944 Total current assets $ 17,133 $ 289 $ 17,422 Current liabilities: Accounts payable 1,619 - 1,619 Accrued expenses 1,529 - 1,529 Insurance Premium Financing - 289 289 Lease liability, current portion 114 - 114 Taxes payable 14 - 14 Total current liabilities $ 3,276 $ 289 $ 3,565 Six months Ended June 30, 2022 (In thousands) Consolidated Statement of Cash flows: As Reported Restatement As Restated OPERATING ACTIVITIES: Net loss $ (3,099) $ - $ (3,099) Adjustments to reconcile net loss to net cash flows from operating activities: Depreciation and amortization 382 - 382 Stock-based compensation 386 - 386 Change in allowance for doubtful accounts 5 - 5 Changes in operating assets and liabilities: Accounts receivable (1,428) - (1,428) Inventory (916) - (916) Prefunded insurance premiums from financing - 614 614 Prepaid expenses and other current assets (585) - (585) Other assets 25 - 25 Accounts payable 383 - 383 Accrued expenses (43) - (43) Taxes payable 6 - 6 Other liabilities 1 - 1 Net cash used in operating activities $ (4,883) $ 614 $ (4,269) FINANCING ACTIVITIES: Proceeds from issuance of convertible notes, net $ 2,354 $ - $ 2,354 Repayments on Insurance financing, net of additional financing - (614) (614) Proceeds from issuance of common stock and warrants, net 7,152 - 7,152 Net cash provided by financing activities $ 9,506 $ (614) $ 8,892 The impacts of the restatement have been reflected throughout the financial statements, including the applicable footnotes, as appropriate.
Use of Estimates, Policy [Policy Text Block]	Use of estimates The preparation of the consolidated financial statements requires management to make a number of estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and cash equivalents We consider all highly liquid short-term investments with an original or remaining maturity of three
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair value of financial instruments Applicable accounting standards define fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). We measure our assets and liabilities using inputs from the following three 1 2 not 3 The carrying amounts for cash and cash equivalents, receivables, and payables approximate fair value due to the short-term maturity of these instruments.
Accounts Receivable [Policy Text Block]	Accounts receivable Our accounts receivable balance primarily includes balances from trade sales to distributors and retail customers. The allowance for doubtful accounts is our best estimate of the amount of probable credit losses in our existing accounts receivable. We determine the allowance for doubtful accounts based primarily on historical write-off experience. Account balances that are deemed uncollectible, are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Allowances for doubtful accounts of approximately $110,000 and $114,000 as of December 31, 2022 2021, Activity in the allowance for doubtful accounts consists of the following for the years ended December 31 ( 2022 2021 Balance, beginning of year $ 114 $ 93 Net charges to bad debt expense (5 ) 42 Recoveries (write-offs) 1 (21 ) Balance, end of year $ 110 $ 114 As of December 31, 2022, two December 31, 2021, one
Inventory, Policy [Policy Text Block]	Inventories Inventories consist of raw materials and finished goods and are stated at the lower of cost or net realizable value and include adjustments for estimated obsolete or excess inventory. Cost is based on actual cost on a first first twelve may December 31, 2022 2021,
Property, Plant and Equipment, Policy [Policy Text Block]	Fixed assets Fixed assets are recorded at cost less accumulated depreciation and are depreciated on the declining balance basis over the estimated useful lives of the assets as follows: Asset Rate Equipment 20% to 30% Vehicles and office and computer equipment 30%
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Impairment of long-lived assets Long-lived assets, which include fixed assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign currency translation The functional currency of our Canadian subsidiary is the Canadian dollar. We translate assets and liabilities related to these operations to U.S. dollars at the exchange rate in effect at the date of the consolidated balance sheet; we convert revenues and expenses into U.S. dollars using the average monthly exchange rates. Translation gains and losses are reported as a separate component of accumulated other comprehensive income. Transaction gains and losses arising from the transactions denominated in a currency other than the functional currency are included in other expense, net in the accompanying consolidated statement of operations. Net transaction loss was $7,000 for 2022 2021.
Revenue from Contract with Customer [Policy Text Block]	Revenue recognition The Company recognizes revenue under Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers 606” five five Step 1: Step 2: Step 3: Step 4: Step 5: See Note 11, Because the Company’s agreements have an expected duration of one 606 10 50 14 not Our contracts have a single performance obligation which is satisfied at the point in time when the customer has title and the significant risks and rewards of ownership of the product. Title and the significant risk and rewards of ownership are deemed to transfer when products are loaded onto a truck for shipment or Free on Board (“FOB”) shipping point. The Company primarily receives fixed consideration for sales of product, subject to adjustment as described below. Shipping and handling amounts paid by customers are primarily for online orders, and are included in revenue, and totaled $163,000 and $120,000 for the years ended December 31, 2022 2021, Revenue is recorded net of provisions for discounts, slotting fees payable by us to retailers to stock our products and promotion allowances. Discounts, slotting fees and promotional allowances vary the consideration the Company is entitled to in exchange for the sale of products to distributors. The Company estimates these discounts, slotting fees and promotional allowances in the same period that the revenue is recognized for product sales to customers. These estimates are based on contract terms and our historical experience with similar programs and require management judgement with respect to estimating customer participation and performance levels. Differences between estimated expense and actual costs are normally insignificant and are recognized in earnings in the period such differences are determined. The amount of revenue recognized represents the amount that will not December 31, 2022 2021, All sales to distributors and customers are generally final. In limited instances we may not 30 15
Advertising Cost [Policy Text Block]	Advertising costs Advertising costs, which also include promotions and sponsorships, are expensed as incurred. During the years ended December 31, 2022 2021,
Income Tax, Policy [Policy Text Block]	Income taxes We account for income taxes by recognizing the amount of taxes payable for the current year and deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in our financial statements. Under this method, deferred tax assets and liabilities are determined on the basis of the differences between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse. We perform periodic evaluations of recorded tax assets and liabilities and maintain a valuation allowance, if considered necessary based on whether they are more likely than not December 31, 2022 2021.
Earnings Per Share, Policy [Policy Text Block]	Net loss per share Basic net loss per share is computed using the weighted average number of common shares outstanding during the periods. Diluted earnings per share is computed by adjusting the weighted average number of common shares by the effective net exercise or conversion of all dilutive securities. Due to the net loss in 2022 2021, 2018
Comprehensive Income, Policy [Policy Text Block]	Comprehensive loss Comprehensive loss is comprised of net loss and translation adjustments. We do not
Seasonal Nature of Business [Policy Text Block]	Seasonality Our sales are seasonal and we experience fluctuations in quarterly results as a result of many factors. We historically have generated a greater percentage of our revenues during the warm weather months of April September. may may not not
Deferred Charges, Policy [Policy Text Block]	Deferred financing costs We defer costs related to the issuance of debt which are included on the accompanying balance sheets as a deduction from the debt liability. Deferred financing costs are amortized over the term of the related loan and are included as a component of interest expense on the accompanying consolidated statements of operations.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent accounting guidance No 2022

Note 1 - Nature of Operations_2

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]	As of December 31, 2021 (In thousands) Consolidated Balance Sheet: As Reported Restatement As Restated Current assets: Cash and cash equivalents $ 4,667 $ - $ 4,667 Accounts receivable, net of allowance of $ 114 2,662 - 2,662 Inventory 1,923 - 1,923 Prefunded insurance premiums from financing - 903 903 Prepaid expenses and other current assets 358 - 358 Total current assets $ 9,610 $ 903 $ 10,513 Current liabilities: Accounts payable 1,239 - 1,239 Accrued expenses 1,544 - 1,544 Insurance Premium Financing - 903 903 Lease liability, current portion 109 - 109 Taxes payable 8 - 8 Current portion of convertible subordinated notes payable, net 92 - 92 Current portion of accrued interest expense 55 - 55 2022 Financing Proceeds Received, Net of Closing Costs 538 - 538 Total current liabilities $ 3,585 $ 903 $ 4,488 Year Ended December 31, 2021 (In thousands) Consolidated Statement of Cash flows: As Reported Restatement As Restated OPERATING ACTIVITIES: Net loss $ (1,811) $ - $ (1,811) Adjustments to reconcile net loss to net cash flows from operating activities: Depreciation and amortization 166 - 166 Stock-based compensation 144 - 144 Change in allowance for doubtful accounts 21 - 21 Forgiveness of PPP SBA loan (335) - (335) Loss (gain) on sale of fixed asset 5 - 5 Changes in operating assets and liabilities: Accounts receivable (1,129) - (1,129) Inventory (66) - (66) Prefunded insurance premiums from financing - (903) (903) Prepaid expenses and other current assets (164) - (164) Accounts payable (147) - (147) Accrued expenses 783 - 783 Taxes payable 1 - 1 Other liabilities 4 - 4 Net cash used in operating activities (2,528) (903) (3,431) FINANCING ACTIVITIES: Proceeds from exercise of stock options $ 296 $ - $ 296 Proceeds from issuance of convertible notes, net 1,778 - 1,778 Proceeds from 2022 convertible notes prior to close, net 538 - 538 Additional financing for insurance premiums, net of repayments - 903 903 Net cash provided by financing activities $ 2,612 $ 903 $ 3,515 As of March 31, 2022 (In thousands) Consolidated Balance Sheet: As Reported Restatement As Restated Current assets: Cash and cash equivalents $ 11,856 $ - $ 11,856 Accounts receivable, net of allowance of $ 111 3,216 - 3,216 Inventory 2,907 - 2,907 Prefunded insurance premiums from financing - 597 597 Prepaid expenses and other current assets 477 - 477 Total current assets $ 18,456 $ 597 $ 19,053 Current liabilities: Accounts payable 1,735 - 1,735 Accrued expenses 1,526 - 1,526 Insurance Premium Financing - 597 597 Lease liability, current portion 111 - 111 Taxes payable 9 - 9 Current portion of convertible subordinated notes payable, net 2,893 - 2,893 Total current liabilities $ 6,274 $ 597 $ 6,871 Quarter Ended March 31, 2022 (In thousands) Consolidated Statement of Cash flows: As Reported Restatement As Restated OPERATING ACTIVITIES: Net loss $ (1,664) $ - $ (1,664) Adjustments to reconcile net loss to net cash flows from operating activities: Depreciation and amortization 247 - 247 Stock-based compensation 268 - 268 Change in allowance for doubtful accounts (3) - (3) Changes in operating assets and liabilities: Accounts receivable (545) - (545) Inventory (982) - (982) Prefunded insurance premiums from financing - 306 306 Prepaid expenses and other current assets (119) - (119) Other assets 25 - 25 Accounts payable 496 - 496 Accrued expenses (66) - (66) Taxes payable 1 - 1 Other liabilities 1 - 1 Net cash used in operating activities $ (2,341) $ 306 $ (2,035) FINANCING ACTIVITIES: Proceeds from issuance of convertible notes, net $ 2,354 $ - $ 2,354 Repayments on Insurance financing, net of additional financing - (306) (306) Proceeds from issuance of common stock and warrants, net 7,152 - 7,152 Net cash provided by financing activities $ 9,506 $ (306) $ 9,200 As of June 30, 2022 (In thousands) Consolidated Balance Sheet: As Reported Restatement As Restated Current assets: Cash and cash equivalents $ 9,285 $ - $ 9,285 Accounts receivable, net of allowance of $ 119 4,071 - 4,071 Inventory 2,833 - 2,833 Prefunded insurance premiums from financing - 289 289 Prepaid expenses and other current assets 944 - 944 Total current assets $ 17,133 $ 289 $ 17,422 Current liabilities: Accounts payable 1,619 - 1,619 Accrued expenses 1,529 - 1,529 Insurance Premium Financing - 289 289 Lease liability, current portion 114 - 114 Taxes payable 14 - 14 Total current liabilities $ 3,276 $ 289 $ 3,565 Six months Ended June 30, 2022 (In thousands) Consolidated Statement of Cash flows: As Reported Restatement As Restated OPERATING ACTIVITIES: Net loss $ (3,099) $ - $ (3,099) Adjustments to reconcile net loss to net cash flows from operating activities: Depreciation and amortization 382 - 382 Stock-based compensation 386 - 386 Change in allowance for doubtful accounts 5 - 5 Changes in operating assets and liabilities: Accounts receivable (1,428) - (1,428) Inventory (916) - (916) Prefunded insurance premiums from financing - 614 614 Prepaid expenses and other current assets (585) - (585) Other assets 25 - 25 Accounts payable 383 - 383 Accrued expenses (43) - (43) Taxes payable 6 - 6 Other liabilities 1 - 1 Net cash used in operating activities $ (4,883) $ 614 $ (4,269) FINANCING ACTIVITIES: Proceeds from issuance of convertible notes, net $ 2,354 $ - $ 2,354 Repayments on Insurance financing, net of additional financing - (614) (614) Proceeds from issuance of common stock and warrants, net 7,152 - 7,152 Net cash provided by financing activities $ 9,506 $ (614) $ 8,892
Accounts Receivable, Allowance for Credit Loss [Table Text Block]	2022 2021 Balance, beginning of year $ 114 $ 93 Net charges to bad debt expense (5 ) 42 Recoveries (write-offs) 1 (21 ) Balance, end of year $ 110 $ 114
Schedule of Depreciation Rate of Property, Plant and Equipment [Table Text Block]	Asset Rate Equipment 20% to 30% Vehicles and office and computer equipment 30%

Note 2 - Inventory (Tables)

Note 2 - Inventory (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Schedule of Inventory, Current [Table Text Block]	December 31, 2022 December 31, 2021 Finished goods $ 1,234 $ 1,361 Raw materials 1,387 562 $ 2,621 $ 1,923

Note 3 - Fixed Assets (Tables)

Note 3 - Fixed Assets (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Property, Plant and Equipment [Table Text Block]	2022 2021 Vehicles $ 37 $ 496 Equipment 210 210 Office and computer equipment 189 159 436 865 Accumulated depreciation (309 ) (627 ) $ 127 $ 238

Note 4 - Accrued Expenses (Tabl

Note 4 - Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Schedule of Accrued Liabilities [Table Text Block]	2022 2021 Employee benefits $ 604 $ 405 Selling and marketing 465 354 Other accruals 575 785 $ 1,644 $ 1,544

Note 7 - Shareholders' Equity (

Note 7 - Shareholders' Equity (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Share-Based Payment Arrangement, Option, Activity [Table Text Block]	Outstanding Options Number of Shares Weighted Average Exercise Price (Per Share) Balance at January 1, 2022 3,405,511 $ 0.38 Options granted 828,148 0.51 Options forfeited/expired (864,327 ) 0.41 Balance at December 31, 2022 3,369,332 $ 0.41 Exercisable, December 31, 2022 2,460,674 $ 0.34 Vested and expected to vest 3,116,129 $ 0.40 Outstanding Options Number of Shares Weighted Average Exercise Price (Per Share) Balance at January 1, 2021 3,589,783 $ 0.36 Options granted 1,423,450 0.49 Options exercised (797,306 ) 0.37 Options forfeited/expired (810,416 ) 0.48 Balance at December 31, 2021 3,405,511 $ 0.38 Exercisable, December 31, 2021 1,616,439 $ 0.34 Vested and expected to vest 2,808,039 $ 0.37
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]	Number Outstanding Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price Per Share Number Exercisable Weighted Average Remaining Contractual Life (Years) Weighted Average Exercise Price Per Share $0.15 to $0.50 2,835,258 7.13 $ 0.34 2,240,258 6.55 $ 0.31 $0.51 to $1.09 529,074 8.65 0.78 215,416 8.26 0.73 $1.10 to $2.99 5,000 8.59 1.33 5,000 8.59 1.33 3,369,332 7.37 0.41 2,460,674 6.70 0.34
Nonvested Restricted Stock Shares Activity [Table Text Block]	Restricted Shares Weighted-Average Grant Date Fair Value per share Weighted-Average Contractual Life (years) Non-vested restricted stock at January 1, 2022 - $ - - Granted 4,920,000 0.20 - Vested (70,000 ) 0.22 Cancelled/expired/rescinded (4,850,000 ) 0.20 Non-vested restricted stock at December 31, 2022 - $ - -
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Year Ended December 31, 2022 2021 Stock options $ 353 $ 162 Pinestar warrants (defined below) 76 - Restricted stock 935 12 $ 1,364 $ 174 Income statement account: Selling and marketing $ 843 $ 65 General and administrative 521 109 $ 1,364 $ 174
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Year Ended December 31, 2022 2021 Expected dividend yield — — Expected stock price volatility 79.3 % 74.7 % Risk-free interest rate 2.2 % 0.9 % Expected term (in years) 6.0 5.8 Weighted-average grant date fair-value $ 0.35 $ 0.32
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]	Number Outstanding Remaining Contractual Life (Years) Exercise Price Per Share Number Exercisable Jones Special Warrants (1) 26,047,137 1.20 $ 0.63 USD 26,047,137 Pinestar Warrants (2) 1,674,808 1.25 0.06 CAD 1,674,808 Outstanding Warrants as of December 31, 2022 27,721,945 27,721,945

Note 10 - Income Taxes (Tables)

Note 10 - Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	2022 2021 Current State $ 7 $ 4 Foreign 21 23 Provision for income taxes $ 28 $ 27
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]	2022 2021 United States $ (6,469 ) $ (1,881 ) Foreign 93 97 Total $ (6,376 ) $ (1,784 )
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	2022 2021 Federal statutory rate 21.00 % 21.00 % Effect of: Permanent differences (1.17 ) 3.84 Stock Compensation (0.85 ) 0.11 State income taxes, net of federal benefit 0.77 3.10 Change in valuation allowance (16.20 ) (10.27 ) Other, net (3.99 ) (19.30 ) Provision for income taxes (0.44 )% (1.51 )%
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	2022 2021 Federal and state net operating loss carryforwards $ 15,765 $ 14,896 Stock-based compensation 212 125 Other, net 205 157 Total deferred tax asset 16,182 15,178 Valuation allowance (16,182 ) (15,178 Net deferred tax asset $ — $ —

Note 11 - Segment Information (

Note 11 - Segment Information (Tables)	12 Months Ended
	Dec. 31, 2022
Notes Tables
Revenue from External Customers by Geographic Areas [Table Text Block]	Year Ended December 31, 2022 2021 Revenue: United States $ 15,313 $ 11,385 Canada 3,609 3,240 Other countries 163 167 Total revenue $ 19,085 $ 14,792

Note 1 - Nature of Operations_3

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details Textual)					3 Months Ended	6 Months Ended	12 Months Ended
	Nov. 15, 2022 USD ($)	May 16, 2022 shares	Feb. 15, 2022 shares	Nov. 15, 2021 USD ($)	Mar. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($) shares	Dec. 31, 2021 USD ($) shares	Dec. 31, 2020 USD ($)
Cash and Cash Equivalents, at Carrying Value, Total					$ 11,856,000	$ 9,285,000	$ 7,971,000	$ 4,667,000
Working Capital (Deficit)							11,600,000	6,000,000
Net Cash Provided by (Used in) Operating Activities, Total					(2,035,000)	(4,269,000)	(5,957,000)	(3,431,000)
Net Cash Provided by (Used in) Financing Activities, Total					9,200,000	8,892,000	9,214,000	3,515,000
Net Income (Loss) Attributable to Parent, Total					(1,664,000)	(3,099,000)	(6,404,000)	(1,811,000)
Retained Earnings (Accumulated Deficit), Total							(78,200,000)	(71,796,000)
Proceeds from Stock Options Exercised							0	296,000
Assets, Current, Total					19,053,000	17,422,000	14,975,000	10,513,000
Prepaid Insurance, Current					597,000	289,000	612,000	903,000
Accrued Insurance, Current					597,000	289,000	612,000	903,000
Liabilities, Current, Total					6,871,000	3,565,000	3,335,000	4,488,000
Accounts Receivable, Allowance for Credit Loss, Current					$ 111,000	$ 119,000	110,000	114,000
Inventory Valuation Reserves							156,000	27,000
Foreign Currency Transaction Gain (Loss), Realized							7,000	18,000
Revenues, Total							19,085,000	14,792,000
Slotting Fees and Promotional Allowances							$ 1,600,000	1,400,000
Maximum Discount for Customers, Payment Made Within 15 Days							2%
Advertising Expense							$ 1,000,000	731,000
Liability for Uncertainty in Income Taxes, Current							$ 0	$ 0	$ 0
Share-Based Payment Arrangement, Option [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares							3,369,332	3,405,511
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares							27,721,945	0
Convertible Debt Securities [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | shares							0	5,372,440
Shipping and Handling [Member]
Revenues, Total							$ 163,000	$ 120,000
Customer Concentration Risk [Member] | Accounts Receivable [Member]
Number of Major Customers							2	1
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Two Customers [Member]
Concentration Risk, Percentage							22%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | One Customer [Member]
Concentration Risk, Percentage								19%
Error Surrounding Short-term Financing [Member]
Assets, Current, Total								$ 903,000
Prepaid Insurance, Current								903,000
Accrued Insurance, Current								903,000
Liabilities, Current, Total								$ 903,000
Contingent Convertible Debentures [Member]
Debt Instrument, Face Amount							$ 3,000,000
Debt Conversion, Converted Instrument, Shares Issued (in shares) | shares		6,022,192
Pinestar Subscription Receipt Offering [Member]
Proceeds from a Subscription Receipt, Net							$ 7,100,000
Stock Issued During Period, Shares, New Issues (in shares) | shares			20,000,048
IPFS Corporation Insurance Agreement [Member]
Debt Instrument, Face Amount	$ 612,000			$ 903,000
Debt Instrument, Term (Year)	1 year			1 year
Deposit Contracts, Assets				$ 903,000

Note 1 - Nature of Operations_4

Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Schedule of Restatement of Previously Issued Consolidated Financial Statements (Details) - USD ($)		3 Months Ended	6 Months Ended	12 Months Ended
	Feb. 09, 2022	Mar. 31, 2022	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021
Cash and cash equivalents		$ 11,856,000	$ 9,285,000	$ 7,971,000	$ 4,667,000
Accounts receivable, net of allowance of $110 and $114, respectively		3,216,000	4,071,000	3,170,000	2,662,000
Inventory		2,907,000	2,833,000	2,621,000	1,923,000
Prefunded insurance premiums - Financing		597,000	289,000	612,000	903,000
Prepaid expenses and other current assets		477,000	944,000	601,000	358,000
Total current assets		19,053,000	17,422,000	14,975,000	10,513,000
Accounts payable		1,735,000	1,619,000	1,069,000	1,239,000
Accrued expenses		1,526,000	1,529,000	1,644,000	1,544,000
Insurance premium financing		597,000	289,000	612,000	903,000
Lease liability, current portion		111,000	114,000	0	109,000
Taxes payable		9,000	14,000	10,000	8,000
Convertible notes payable		2,893,000
Current portion of accrued interest expense				0	55,000
Total current liabilities		6,871,000	3,565,000	3,335,000	4,488,000
Net loss		(1,664,000)	(3,099,000)	(6,404,000)	(1,811,000)
Depreciation and amortization		247,000	382,000	414,000	166,000
Stock-based compensation		268,000	386,000	1,364,000	144,000
Change in allowance for doubtful accounts		(3,000)	5,000	(4,000)	21,000
Forgiveness of PPP SBA loan				0	(335,000)
Loss (gain) on sale of fixed asset				(31,000)	5,000
Accounts receivable		(545,000)	(1,428,000)	(542,000)	(1,129,000)
Inventory		(982,000)	(916,000)	(714,000)	(66,000)
Prefunded insurance premiums from financing		306,000	614,000	292,000	(903,000)
Prepaid expenses and other current assets		(119,000)	(585,000)	(243,000)	(164,000)
Accounts payable		496,000	383,000	(167,000)	(147,000)
Accrued expenses		(66,000)	(43,000)	73,000	783,000
Taxes payable		1,000	6,000	3,000	1,000
Other liabilities		1,000	1,000	(10,000)	4,000
Net cash used in operating activities		(2,035,000)	(4,269,000)	(5,957,000)	(3,431,000)
Proceeds from exercise of stock options				0	296,000
Proceeds from issuance of convertible notes		2,354,000	2,354,000
Additional financing for insurance premiums, net of repayments		(306,000)	(614,000)	(292,000)	903,000
Net cash provided by financing activities		9,200,000	8,892,000	9,214,000	3,515,000
Other assets		25,000	25,000	(35,000)	0
Repayments on Insurance financing, net of additional financing		(306,000)	(614,000)	(292,000)	0
Proceeds from issuance of common stock and warrants, net		7,152,000	7,152,000	7,152,000	0
Convertible Subordinated Notes Payable [Member]
Convertible notes payable				0	92,000
Proceeds from issuance of convertible notes				2,354,000	1,778,000
Contingent Convertible Debentures [Member]
Convertible notes payable				0	538,000
Proceeds from issuance of convertible notes	$ 3,000,000	3,000,000		$ 0	538,000
Previously Reported [Member]
Cash and cash equivalents		11,856,000	9,285,000		4,667,000
Accounts receivable, net of allowance of $110 and $114, respectively		3,216,000	4,071,000		2,662,000
Inventory		2,907,000	2,833,000		1,923,000
Prepaid expenses and other current assets		477,000	944,000		358,000
Total current assets		18,456,000	17,133,000		9,610,000
Accounts payable		1,735,000	1,619,000		1,239,000
Accrued expenses		1,526,000	1,529,000		1,544,000
Lease liability, current portion		111,000	114,000		109,000
Taxes payable		9,000	14,000		8,000
Convertible notes payable		2,893,000
Current portion of accrued interest expense					55,000
Total current liabilities		6,274,000	3,276,000		3,585,000
Net loss		(1,664,000)	(3,099,000)		(1,811,000)
Depreciation and amortization		247,000	382,000		166,000
Stock-based compensation		268,000	386,000		144,000
Change in allowance for doubtful accounts		(3,000)	5,000		21,000
Forgiveness of PPP SBA loan					(335,000)
Loss (gain) on sale of fixed asset					5,000
Accounts receivable		(545,000)	(1,428,000)		(1,129,000)
Inventory		(982,000)	(916,000)		(66,000)
Prepaid expenses and other current assets		(119,000)	(585,000)		(164,000)
Accounts payable		496,000	383,000		(147,000)
Accrued expenses		(66,000)	(43,000)		783,000
Taxes payable		1,000	6,000		1,000
Other liabilities		1,000	1,000		4,000
Net cash used in operating activities		(2,341,000)	(4,883,000)		(2,528,000)
Proceeds from exercise of stock options					296,000
Proceeds from issuance of convertible notes		2,354,000	2,354,000
Net cash provided by financing activities		9,506,000	9,506,000		2,612,000
Other assets		25,000	25,000
Proceeds from issuance of common stock and warrants, net		7,152,000	7,152,000
Previously Reported [Member] | Convertible Subordinated Notes Payable [Member]
Convertible notes payable					92,000
Proceeds from issuance of convertible notes					1,778,000
Previously Reported [Member] | Contingent Convertible Debentures [Member]
Convertible notes payable					538,000
Proceeds from issuance of convertible notes					538,000
Revision of Prior Period, Error Correction, Adjustment [Member]
Prefunded insurance premiums - Financing		597,000	289,000		903,000
Total current assets		597,000	289,000		903,000
Insurance premium financing		597,000	289,000		903,000
Total current liabilities		597,000	289,000		903,000
Prefunded insurance premiums from financing		306,000	614,000		(903,000)
Net cash used in operating activities		306,000	614,000		(903,000)
Additional financing for insurance premiums, net of repayments		(306,000)	(614,000)		903,000
Net cash provided by financing activities		(306,000)	(614,000)		$ 903,000
Repayments on Insurance financing, net of additional financing		$ (306,000)	$ (614,000)

Note 1 - Nature of Operations_5

Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Schedule of Restatement of Previously Issued Consolidated Financial Statements (Details) (Parentheticals) - USD ($)	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Accounts receivable, allowance	$ 110,000	$ 119,000	$ 111,000	$ 114,000

Note 1 - Nature of Operations_6

Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Activity in the Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Balance, beginning of year	$ 114	$ 93
Net charges to bad debt expense	(5)	42
Recoveries (write-offs)	1	(21)
Balance, end of year	$ 110	$ 114

Note 1 - Nature of Operations_7

Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Depreciation on Fixed Assets (Details)	12 Months Ended
	Dec. 31, 2022
Equipment [Member] | Minimum [Member]
Depreciation rate	20%
Equipment [Member] | Maximum [Member]
Depreciation rate	30%
Vehicles and Office and Computer Equipment [Member]
Depreciation rate	30%

Note 2 - Inventory - Inventory

Note 2 - Inventory - Inventory (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Finished goods	$ 1,234			$ 1,361
Raw materials	1,387			562
Inventory, Net, Total	$ 2,621	$ 2,833	$ 2,907	$ 1,923

Note 3 - Fixed Assets (Details

Note 3 - Fixed Assets (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Depreciation, Total	$ 66,000	$ 93,000
Gain on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property	54,000
Loss on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property	$ 5,000

Note 3 - Fixed Assets - Fixed A

Note 3 - Fixed Assets - Fixed Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Property, plant and equipment, gross	$ 436	$ 865
Accumulated depreciation	(309)	(627)
Property, Plant and Equipment, Net, Total	127	238
Vehicles [Member]
Property, plant and equipment, gross	37	496
Equipment [Member]
Property, plant and equipment, gross	210	210
Office and Computer Equipment [Member]
Property, plant and equipment, gross	$ 189	$ 159

Note 4 - Accrued Expenses - Acc

Note 4 - Accrued Expenses - Accrued Expenses (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021
Employee benefits	$ 604			$ 405
Selling and marketing	465			354
Other accruals	575			785
Accrued Liabilities, Current, Total	$ 1,644	$ 1,529	$ 1,526	$ 1,544

Note 5 - Convertible Debentur_2

Note 5 - Convertible Debentures (Details Textual) - USD ($)						3 Months Ended	6 Months Ended	12 Months Ended
	May 16, 2022	Feb. 09, 2022	Jul. 14, 2021	Apr. 18, 2018	Mar. 23, 2018	Mar. 31, 2022	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Sep. 30, 2022
Share Price (in dollars per share)				$ 0.30	$ 0.36
Convertible Notes Payable, Noncurrent								$ 0	$ 1,778,000
Proceeds from Convertible Debt						$ 2,354,000	$ 2,354,000
Stock Issued During Period, Value, Conversion of Convertible Securities								$ 5,147,000	1,621,000
Plan of Arrangement Conversion [Member]
Debt Instrument, Convertible, Conversion Price (in dollars per share)		$ 0.50
Debt Conversion, Converted Instrument, Shares Issued (in shares)		4,025,035
Stock Issued During Period, Value, Conversion of Convertible Securities						2,000,000
Jones Special Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares)		1	1
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 0.625	$ 0.625					$ 0.63
Warrants and Rights Outstanding, Term (Month)			24 months
Plan of Arrangement Warrant Conversion [Member]
Class of Warrant or Right, Exercised (in shares)		4,025,035
Convertible Notes [Member]
Convertible Subordinated Debt, Total				$ 2,920,000	$ 2,920,000
Debt Instrument, Term (Year)				4 years
Debt Instrument, Interest Rate, Stated Percentage				6%
Debt Instrument, Convertible, Conversion Price (in dollars per share)				$ 0.32
Debt Instrument, Convertible, Beneficial Conversion Feature					$ 350,000
Debt Issuance Costs, Gross				$ 137,000
Convertible Notes Payable, Noncurrent										$ 0
Unsecured Convertible Debenture to SOL Verano Blocker 1 LLC [Member]
Debt Instrument, Interest Rate, Stated Percentage		3%	5%
Debt Instrument, Convertible, Conversion Price (in dollars per share)		$ 0.50	$ 0.50
Proceeds from Convertible Debt			$ 2,000,000
Convertible Debt Common Shares Issuable per Unit (in shares)		1	1
Convertible Debt Warrants Issuable per Unit (in shares)		1	1
Interest Payable									47,000
Contingent Convertible Debentures [Member]
Debt Instrument, Interest Rate, Stated Percentage		3%
Debt Issuance Costs, Gross		$ 108,000
Proceeds from Convertible Debt		$ 3,000,000				$ 3,000,000		$ 0	$ 538,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share)		$ 0.50
Debt Conversion, Converted Instrument, Shares Issued (in shares)	6,022,192
Convertible Debt, Total										$ 0

Note 6 - Lease Obligations (Det

Note 6 - Lease Obligations (Details Textual)	12 Months Ended
	Dec. 31, 2022 USD ($) ft²	Dec. 31, 2021 USD ($)	Sep. 01, 2022 USD ($)	Feb. 28, 2020 USD ($)
Operating Lease, Right-of-Use Asset	$ 0	$ 365,000
Nonoperating Income (Expense), Total	88,000	344,000
Operating Lease, Expense	$ 109,000	$ 122,000
Retail / Office Space in Seattle, Washington [Member]
Area of Real Estate Property (Square Foot) | ft²	6,500
Lessee, Operating Lease, Term of Contract (Year)				5 years
Operating Lease, Right-of-Use Asset				$ 556,000
Lessee, Operating Lease, Discount Rate	4%
Operating Lease, Right-of-use Asset, Terminated	$ 310,000
Operating Lease, Liability, Terminated	322,000
Nonoperating Income (Expense), Total	12,000
Lessee, Operating Lease, Termination Fee	41,000
Shared Office and Warehouse Facility in Seattle, WA [Member]
Lessee, Operating Lease, Term of Contract (Year)			1 year
Lessee, Operating Lease, Monthly Rent			$ 6,000
Operating Lease, Expense	$ 29,000

Note 7 - Shareholders' Equity_2

Note 7 - Shareholders' Equity (Details Textual)						12 Months Ended
		May 16, 2022 shares	Feb. 15, 2022 USD ($) $ / shares shares	Jul. 14, 2021 $ / shares shares	Jan. 01, 2020 USD ($)	Dec. 31, 2022 USD ($) $ / shares shares		Dec. 31, 2021 USD ($) shares	Dec. 31, 2022 $ / shares	Feb. 09, 2022 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Total (in shares)						0
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value | $						$ 77,000		$ 1,300,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value | $						77,000		690,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | $						$ 0		$ 435,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period (in shares)						0		797,306
Class of Warrant or Right, Outstanding (in shares)						27,721,945
Share-Based Payment Arrangement, Expense | $						$ 1,364,000		$ 174,000
Jones Special Warrant [Member]
Proceeds from a Subscription Receipt, Net | $						$ 8,000,000
Subscription Receipt, Conversion into Warrants (in shares)						16,000,000
Class of Warrant or Right, Outstanding (in shares)	[1]					26,047,137
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares)				1						1
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares				$ 0.625		$ 0.63				$ 0.625
Pinestar Warrants [Member]
Class of Warrant or Right, Outstanding (in shares)			16,800,000			1,674,808	[2]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares)			10.031			1
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares									$ 0.06
Conversion of 2021 Unsecured Convertible Debenture into Jones Special Warrants [Member]
Debt Conversion, Converted Instrument, Warrants or Options Issued (in shares)				4,025,035
Conversion of 2022 Unsecured Convertible Debenture into Jones Special Warrants [Member]
Debt Conversion, Converted Instrument, Warrants or Options Issued (in shares)						6,022,102
Pinestar Subscription Receipt Offering [Member]
Stock Issued During Period, Shares, New Issues (in shares)			20,000,048
Proceeds from Issuance or Sale of Equity, Total | $			$ 7,152,000
Shares Issued, Price Per Share (in dollars per share) | $ / shares			$ 0.50
Proceeds from a Subscription Receipt, Net | $						$ 7,100,000
Two Board of Director's Members [Member] | Pinestar Warrants [Member]
Class of Warrant or Right, Warrants Issued During Period (in shares)						600,000
Share-Based Payment Arrangement, Expense | $						$ 76,000
Share-Based Payment Arrangement, Option [Member]
Share-Based Payment Arrangement, Expense | $						353,000		$ 162,000
Restricted Stock Units (RSUs) [Member] | Non-employee Directors [Member]
Share-based Payment Arrangement, Expensed and Capitalized, Amount, Total | $					$ 25,000
Stock Options and Non-vested Stock [Member]
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total | $						$ 212,000
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year)						2 years 8 months 12 days
The 2022 Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)		10,000,000
The 2011 Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized (in shares)		11,936,074
Common Stock, Capital Shares Reserved for Future Issuance (in shares)		1,936,074
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant (in shares)						11,663,574
The 2011 Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year)		10 years
[1]Upon conversion of the beforementioned 2021 Unsecured Convertible Debenture, 4,025,035 Jones Special Warrants were issued. In connection with the beforementioned Plan of Arrangement, Pinestar completed an offering for Subscription Receipts for aggregate gross proceeds of $8,000,000. Pursuant to the Plan of Arrangement, each Subscription Receipt automatically converted into 16,000,000 Jones Special Warrants. Lastly, Upon conversion of the beforementioned 2022 Unsecured Convertible Debenture, 6,022,102 Jones Special Warrants were issued.[2]In connection with the beforementioned Plan of Arrangement, Pinestar, Pinestar had outstanding 16,800,000 existing common share purchase warrants and as a result of the consolidation, and the number of Pinestar Shares issuable pursuant to the Pinestar warrants as adjusted in accordance with their terms to account for the consolidation (10.031 pre consolidation shares to 1 post consolidation), resulting in an aggregate of approximately 1,674,808 post-consolidated Pinestar warrants, subject to rounding, each exercisable for the purchase of one post-consolidation Pinestar Share at a price of $0.0602 CAD per share. 600,000 warrants were transferred to two Board of Director members for 2022 services, thus resulting in $76,000 in stock compensation expense incurred during the year ended December 31, 2022

Note 7 - Shareholders' Equity -

Note 7 - Shareholders' Equity - Summary of Stock Option Activity (Details) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Balance, number of shares (in shares)	3,405,511	3,589,783
Balance, weighted average exercise price (in dollars per share)	$ 0.38	$ 0.36
Options granted, number of shares (in shares)	828,148	1,423,450
Options granted, weighted average exercise price (in dollars per share)	$ 0.51	$ 0.49
Options forfeited/expired, number of shares (in shares)	(864,327)	(810,416)
Options forfeited/expired, weighted average exercise price (in dollars per share)	$ 0.41	$ 0.48
Balance, number of shares (in shares)	3,369,332	3,405,511
Balance, weighted average exercise price (in dollars per share)	$ 0.41	$ 0.38
Exercisable, number of shares (in shares)	2,460,674	1,616,439
Exercisable, weighted average exercise price (in dollars per share)	$ 0.34	$ 0.34
Vested and expected to vest, number of shares (in shares)	3,116,129	2,808,039
Vested and expected to vest, weighted average exercise price (in dollars per share)	$ 0.40	$ 0.37
Options exercised, number of shares (in shares)	0	(797,306)
Options exercised, weighted average exercise price (in dollars per share)		$ 0.37

Note 7 - Shareholders' Equity_3

Note 7 - Shareholders' Equity - Stock Options Outstanding and Exercisable (Details)	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Number outstanding (in shares) | shares	3,369,332
Options outstanding, weighted average remaining contractual life (Year)	7 years 4 months 13 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 0.41
Number exercisable (in shares) | shares	2,460,674
Options exercisable, weighted average remaining contractual life (Year)	6 years 8 months 12 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 0.34
Range One [Member]
Exercise price, lower limit (in dollars per share)	0.15
Exercise price, upper limit (in dollars per share)	$ 0.50
Number outstanding (in shares) | shares	2,835,258
Options outstanding, weighted average remaining contractual life (Year)	7 years 1 month 17 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 0.34
Number exercisable (in shares) | shares	2,240,258
Options exercisable, weighted average remaining contractual life (Year)	6 years 6 months 18 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 0.31
Range Two [Member]
Exercise price, lower limit (in dollars per share)	0.51
Exercise price, upper limit (in dollars per share)	$ 1.09
Number outstanding (in shares) | shares	529,074
Options outstanding, weighted average remaining contractual life (Year)	8 years 7 months 24 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 0.78
Number exercisable (in shares) | shares	215,416
Options exercisable, weighted average remaining contractual life (Year)	8 years 3 months 3 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 0.73
Range Three [Member]
Exercise price, lower limit (in dollars per share)	1.10
Exercise price, upper limit (in dollars per share)	$ 2.99
Number outstanding (in shares) | shares	5,000
Options outstanding, weighted average remaining contractual life (Year)	8 years 7 months 2 days
Options outstanding, weighted average exercise price (in dollars per share)	$ 1.33
Number exercisable (in shares) | shares	5,000
Options exercisable, weighted average remaining contractual life (Year)	8 years 7 months 2 days
Options exercisable, weighted average exercise price (in dollars per share)	$ 1.33

Note 7 - Shareholders' Equity_4

Note 7 - Shareholders' Equity - Summary of Restricted Stock Activity (Details) - Restricted Stock [Member]	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Non-vested restricted stock (in shares) | shares	0
Non-vested restricted stock, weighted-average grant date fair value (in dollars per share) | $ / shares	$ 0
Granted (in shares) | shares	4,920,000
Granted, weighted-average grant date fair value (in dollars per share) | $ / shares	$ 0.20
Vested (in shares) | shares	(70,000)
Vested, weighted-average grant date fair value (in dollars per share) | $ / shares	$ 0.22
Cancelled/expired/rescinded (in shares) | shares	(4,850,000)
Cancelled/expired/rescinded, weighted-average grant date fair value (in dollars per share) | $ / shares	$ 0.20
Non-vested restricted stock (in shares) | shares	0
Non-vested restricted stock, weighted-average grant date fair value (in dollars per share) | $ / shares	$ 0

Note 7 - Shareholders' Equity_5

Note 7 - Shareholders' Equity - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Stock-based compensation expense	$ 1,364	$ 174
Selling and Marketing Expense [Member]
Stock-based compensation expense	843	65
General and Administrative Expense [Member]
Stock-based compensation expense	521	109
Share-Based Payment Arrangement, Option [Member]
Stock-based compensation expense	353	162
Pinestar Warrants [Member]
Stock-based compensation expense	76
Restricted Stock [Member]
Stock-based compensation expense	$ 935	$ 12

Note 7 - Shareholders' Equity_6

Note 7 - Shareholders' Equity - Weighted-average Assumptions (Details) - Share-Based Payment Arrangement, Option [Member] - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Expected dividend yield	0%	0%
Expected stock price volatility	79.30%	74.70%
Risk-free interest rate	2.20%	0.90%
Expected term (in years) (Year)	6 years	5 years 9 months 18 days
Weighted-average grant date fair-value (in dollars per share)	$ 0.35	$ 0.32

Note 7 - Stockholders' Equity -

Note 7 - Stockholders' Equity - Schedule of Warrants (Details)		12 Months Ended
		Dec. 31, 2022 $ / shares shares		Dec. 31, 2022 $ / shares shares		Feb. 15, 2022 shares	Feb. 09, 2022 $ / shares	Jul. 14, 2021 $ / shares
Warrants outstanding (in shares)		27,721,945		27,721,945
Warrants, number exercisable (in shares)		27,721,945		27,721,945
Jones Special Warrant [Member]
Warrants outstanding (in shares)	[1]	26,047,137		26,047,137
Warrants, remaining contractual life (Year)		1 year 2 months 12 days
Warrants, exercise price (in dollars per share) | $ / shares		$ 0.63					$ 0.625	$ 0.625
Warrants, number exercisable (in shares)		26,047,137		26,047,137
Pinestar Warrants [Member]
Warrants outstanding (in shares)		1,674,808	[2]	1,674,808	[2]	16,800,000
Warrants, remaining contractual life (Year)		1 year 3 months
Warrants, exercise price (in dollars per share) | $ / shares				$ 0.06
Warrants, number exercisable (in shares)		1,674,808		1,674,808
[1]Upon conversion of the beforementioned 2021 Unsecured Convertible Debenture, 4,025,035 Jones Special Warrants were issued. In connection with the beforementioned Plan of Arrangement, Pinestar completed an offering for Subscription Receipts for aggregate gross proceeds of $8,000,000. Pursuant to the Plan of Arrangement, each Subscription Receipt automatically converted into 16,000,000 Jones Special Warrants. Lastly, Upon conversion of the beforementioned 2022 Unsecured Convertible Debenture, 6,022,102 Jones Special Warrants were issued.[2]In connection with the beforementioned Plan of Arrangement, Pinestar, Pinestar had outstanding 16,800,000 existing common share purchase warrants and as a result of the consolidation, and the number of Pinestar Shares issuable pursuant to the Pinestar warrants as adjusted in accordance with their terms to account for the consolidation (10.031 pre consolidation shares to 1 post consolidation), resulting in an aggregate of approximately 1,674,808 post-consolidated Pinestar warrants, subject to rounding, each exercisable for the purchase of one post-consolidation Pinestar Share at a price of $0.0602 CAD per share. 600,000 warrants were transferred to two Board of Director members for 2022 services, thus resulting in $76,000 in stock compensation expense incurred during the year ended December 31, 2022

Note 8 - Employee 401(k) Plan (

Note 8 - Employee 401(k) Plan (Details Textual)	12 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Defined Contribution Plan, Hours of Service in Three Consecutive Months		1
Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent		100%
Defined Contribution Plan, Employer Discretionary Contribution Amount		$ 0	$ 0
Defined Contribution Plan, Employer, Matching Contributions Accrued	$ 42,000

Note 9 - Commitments and Cont_2

Note 9 - Commitments and Contingencies (Details Textual)	Dec. 31, 2022 USD ($)
Recorded Unconditional Purchase Obligation, to be Paid, Year One	$ 1.5
Recorded Unconditional Purchase Obligation, to be Paid, Year Two	$ 0

Note 10 - Income Taxes (Details

Note 10 - Income Taxes (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount	$ 1,000	$ 185,000
Liability for Uncertainty in Income Taxes, Current	$ 0	0	$ 0
Open Tax Year	2017 2018 2019 2020 2021
Domestic Tax Authority [Member] | Internal Revenue Service (IRS) [Member]
Operating Loss Carryforwards, Subject to Expiration	$ 54,900,000
Operating Loss Carryforwards, Not Subject to Expiration	14,800,000
State and Local Jurisdiction [Member] | Internal Revenue Service (IRS) [Member]
Operating Loss Carryforwards, Subject to Expiration		$ 19,500,000
Operating Loss Carryforwards, Not Subject to Expiration	$ 300,000

Note 10 - Income Taxes - Provis

Note 10 - Income Taxes - Provision for Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
State	$ 7	$ 4
Foreign	21	23
Provision for income taxes	$ 28	$ 27

Note 10 - Income Taxes - Loss B

Note 10 - Income Taxes - Loss Before Provision for Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
United States	$ (6,469)	$ (1,881)
Foreign	93	97
Total	$ (6,376)	$ (1,784)

Note 10 - Income Taxes - Income

Note 10 - Income Taxes - Income Tax Rate Reconciliation (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Federal statutory rate	21%	21%
Permanent differences	(1.17%)	3.84%
Stock Compensation	(0.85%)	0.11%
State income taxes, net of federal benefit	0.77%	3.10%
Change in valuation allowance	(16.20%)	(10.27%)
Other, net	(3.99%)	(19.30%)
Provision for income taxes	(0.44%)	(1.51%)

Note 10 - Income Taxes - Compon

Note 10 - Income Taxes - Components of Deferred Income Taxes (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Federal and state net operating loss carryforwards	$ 15,765	$ 14,896
Stock-based compensation	212	125
Other, net	205	157
Total deferred tax asset	16,182	15,178
Valuation allowance	(16,182)	(15,178)
Net deferred tax asset	$ 0	$ 0

Note 11 - Segment Information_2

Note 11 - Segment Information (Details Textual)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Number of Operating Segments	1
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member]
Number of Major Customers	1	1
Revenue from Contract with Customer Benchmark [Member] | Customer Concentration Risk [Member] | One Customer [Member]
Concentration Risk, Percentage	17%	21%

Note 11 - Segment Information -

Note 11 - Segment Information - Geographic Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenue	$ 19,085	$ 14,792
UNITED STATES
Revenue	15,313	11,385
CANADA
Revenue	3,609	3,240
Other Countries [Member]
Revenue	$ 163	$ 167

Note 12 - Insurance Premium F_2

Note 12 - Insurance Premium Financing (Details Textual) - IPFS Corporation Insurance Agreement [Member] - USD ($)	Nov. 15, 2022	Nov. 15, 2021
Debt Instrument, Term (Year)	1 year	1 year
Debt Instrument, Face Amount	$ 612,000	$ 903,000
Short-Term Debt, Weighted Average Interest Rate, at Point in Time	6.99%	4.75%

Note 13 - Related Party Trans_2

Note 13 - Related Party Transaction (Details Textual)			12 Months Ended
	Feb. 15, 2022 USD ($) $ / shares shares	Jan. 06, 2022 USD ($)	Dec. 31, 2022 USD ($) $ / shares shares	Dec. 31, 2022 $ / shares shares	Feb. 09, 2022 USD ($) $ / shares shares	Jul. 14, 2021 $ / shares shares
Jones Special Warrant [Member]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares)					1	1
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares			$ 0.63		$ 0.625	$ 0.625
Proceeds from a Subscription Receipt, Net | $			$ 8,000,000
Pinestar Warrants [Member]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares)	10.031		1	1
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares				$ 0.06
Unsecured Convertible Debenture to SOL Verano Blocker 1 LLC [Member]
Debt Instrument, Interest Rate, Stated Percentage					3%	5%
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares					$ 0.50	$ 0.50
Convertible Debt Common Shares Issuable per Unit (in shares)					1	1
Convertible Debt Warrants Issuable per Unit (in shares)					1	1
Current Director [Member] | Unsecured Convertible Debenture to SOL Verano Blocker 1 LLC [Member]
Debt Instrument, Face Amount | $					$ 100,000
Former Director [Member] | Unsecured Convertible Debenture to SOL Verano Blocker 1 LLC [Member]
Debt Instrument, Face Amount | $					$ 400,000
Current and Former Directors [Member]
Proceeds from a Subscription Receipt, Net | $	$ 200,000
Stock Issued During Period, Shares, New Issues (in shares)	400,000
Current and Former Directors [Member] | Jones Special Warrant [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares	$ 0.625
Class of Warrant or Right, Warrants Issued During Period (in shares)	400,000
Jamie Colbourne [Member] | Pinestar Warrants [Member]
Class of Warrant or Right, Warrants Issued During Period (in shares)			400,000
Paul Norman [Member] | Pinestar Warrants [Member]
Class of Warrant or Right, Warrants Issued During Period (in shares)			200,000
Royalty Agreement [Member] | Julianna Pena [Member]
Related Party Transaction, Amounts of Transaction | $		$ 100,000	$ 136,000
Royalty Percentage		10%